User menu

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

Bibliographic reference Kalincik, Tomas ; Jokubaitis, Vilija ; Izquierdo, Guillermo ; Duquette, Pierre ; Girard, Marc ; et. al. Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis. In: Multiple Sclerosis : clinical and laboratory research, Vol. 21, no. 9, p. 1159-1171 (2014)
Permanent URL http://hdl.handle.net/2078.1/153419
  1. O'Connor Paul, Filippi Massimo, Arnason Barry, Comi Giancarlo, Cook Stuart, Goodin Douglas, Hartung Hans-Peter, Jeffery Douglas, Kappos Ludwig, Boateng Francis, Filippov Vitali, Groth Maria, Knappertz Volker, Kraus Christian, Sandbrink Rupert, Pohl Christoph, Bogumil Timon, 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study, 10.1016/s1474-4422(09)70226-1
  2. SCHWID S, PANITCH H, Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon β-1a for relapsing multiple sclerosis, 10.1016/j.clinthera.2007.09.025
  3. Durelli Luca, Verdun Elisabetta, Barbero Pierangelo, Bergui Mauro, Versino Elisabetta, Ghezzi Angelo, Montanari Enrico, Zaffaroni Mauro, Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN), 10.1016/s0140-6736(02)08430-1
  4. Koch-Henriksen N., Sorensen P. S., Christensen T., Frederiksen J., Ravnborg M., Jensen K., Heltberg A., Kristensen O., Stenager E., Petersen T., Hansen T., , A randomized study of two interferon- beta treatments in relapsing-remitting multiple sclerosis, 10.1212/01.wnl.0000204018.52311.ec
  5. Mikol Daniel D, Barkhof Frederik, Chang Peter, Coyle Patricia K, Jeffery Douglas R, Schwid Steven R, Stubinski Bettina, Uitdehaag Bernard MJ, Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial, 10.1016/s1474-4422(08)70200-x
  6. Lublin Fred D., Cofield Stacey S., Cutter Gary R., Conwit Robin, Narayana Ponnada A., Nelson Flavia, Salter Amber R., Gustafson Tarah, Wolinsky Jerry S., , Randomized study combining interferon and glatiramer acetate in multiple sclerosis : The CombiRx Study, 10.1002/ana.23863
  7. Trojano M, Int MS J, 16, 90 (2009)
  8. Rosenbaum Paul R., Rubin Donald B., Reducing Bias in Observational Studies Using Subclassification on the Propensity Score, 10.1080/01621459.1984.10478078
  9. Trojano Maria, Pellegrini Fabio, Fuiani Aurora, Paolicelli Damiano, Zipoli Valentina, Zimatore Giovanni B., Di Monte Elisabetta, Portaccio Emilio, Lepore Vito, Livrea Paolo, Amato Maria Pia, New natural history of interferon-β-treated relapsing multiple sclerosis, 10.1002/ana.21102
  10. Conway Devon S, Miller Deborah M, O’Brien Ralph G, Cohen Jeffrey A, Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique, 10.1177/1352458512449681
  11. Shirani Afsaneh, Zhao Yinshan, Karim Mohammad Ehsanul, Evans Charity, Kingwell Elaine, van der Kop Mia L., Oger Joel, Gustafson Paul, Petkau John, Tremlett Helen, Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis, 10.1001/jama.2012.7625
  12. Kalincik Tomas, Vivek Vino, Jokubaitis Vilija, Lechner-Scott Jeannette, Trojano Maria, Izquierdo Guillermo, Lugaresi Alessandra, Grand’Maison Francois, Hupperts Raymond, Oreja-Guevara Celia, Bergamaschi Roberto, Iuliano Gerardo, Alroughani Raed, Van Pesch Vincent, Amato Maria Pia, Slee Mark, Verheul Freek, Fernandez-Bolanos Ricardo, Fiol Marcela, Spitaleri Daniele La, Cristiano Edgardo, Gray Orla, Cabrera-Gomez Jose Antonio, Shaygannejad Vahid, Herbert Joseph, Vucic Steve, Needham Merilee, Petkovska-Boskova Tatjana, Sirbu Carmen-Adella, Duquette Pierre, Girard Marc, Grammond Pierre, Boz Cavit, Giuliani Giorgio, Rio Maria Edite, Barnett Michael, Flechter Shlomo, Moore Fraser, Singhal Bhim, Bacile Elizabeth Alejandra, Saladino Maria Laura, Shaw Cameron, Skromne Eli, Poehlau Dieter, Vella Norbert, Spelman Timothy, Liew Danny, Kilpatrick Trevor J., Butzkueven Helmut, Sex as a determinant of relapse incidence and progressive course of multiple sclerosis, 10.1093/brain/awt281
  13. Ebers George C, Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis, 10.1016/s0140-6736(98)03334-0
  14. Butzkueven H, Chapman J, Cristiano E, Grand’Maison F, Hoffmann M, Izquierdo G, Jolley D, Kappos L, Leist T, Pöhlau D, Rivera V, Trojano M, Verheul F, Malkowski J-P, MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis, 10.1177/1352458506070775
  15. Polman Chris H., Reingold Stephen C., Edan Gilles, Filippi Massimo, Hartung Hans-Peter, Kappos Ludwig, Lublin Fred D., Metz Luanne M., McFarland Henry F., O'Connor Paul W., Sandberg-Wollheim Magnhild, Thompson Alan J., Weinshenker Brian G., Wolinsky Jerry S., Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”, 10.1002/ana.20703
  16. Polman Chris H., Reingold Stephen C., Banwell Brenda, Clanet Michel, Cohen Jeffrey A., Filippi Massimo, Fujihara Kazuo, Havrdova Eva, Hutchinson Michael, Kappos Ludwig, Lublin Fred D., Montalban Xavier, O'Connor Paul, Sandberg-Wollheim Magnhild, Thompson Alan J., Waubant Emmanuelle, Weinshenker Brian, Wolinsky Jerry S., Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, 10.1002/ana.22366
  17. Lublin F. D., Reingold S. C., , Defining the clinical course of multiple sclerosis: Results of an international survey, 10.1212/wnl.46.4.907
  18. Schumacher George A., Beebe Gilbert, Kibler Robert F., Kurland Leonard T., Kurtzke John F., McDowell Fletcher, Nagler Benedict, Sibley William A., Tourtellotte Wallace W., Willmon Thomas L., PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS, 10.1111/j.1749-6632.1965.tb20235.x
  19. R Development Core Team, R: A language and environment for statistical computing (2011)
  20. Ho Daniel E., Imai Kosuke, King Gary, Stuart Elizabeth A., Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal Inference, 10.1093/pan/mpl013
  21. Imai Kosuke, King Gary, Lau Olivia, Toward a Common Framework for Statistical Analysis and Development, 10.1198/106186008x384898
  22. Kalincik Tomas, Spelman Timothy, Trojano Maria, Duquette Pierre, Izquierdo Guillermo, Grammond Pierre, Lugaresi Alessandra, Hupperts Raymond, Cristiano Edgardo, Van Pesch Vincent, Grand’Maison Francois, La Spitaleri Daniele, Rio Maria Edite, Flechter Sholmo, Oreja-Guevara Celia, Giuliani Giorgio, Savino Aldo, Amato Maria Pia, Petersen Thor, Fernandez-Bolanos Ricardo, Bergamaschi Roberto, Iuliano Gerardo, Boz Cavit, Lechner-Scott Jeannette, Deri Norma, Gray Orla, Verheul Freek, Fiol Marcela, Barnett Michael, van Munster Erik, Santiago Vetere, Moore Fraser, Slee Mark, Saladino Maria Laura, Alroughani Raed, Shaw Cameron, Kasa Krisztian, Petkovska-Boskova Tatjana, Braber-Moerland Leontien den, Chapman Joab, Skromne Eli, Herbert Joseph, Poehlau Dieter, Needham Merrilee, Bacile Elizabeth Alejandra Bacile, Arruda Walter Oleschko, Paine Mark, Singhal Bhim, Vucic Steve, Cabrera-Gomez Jose Antonio, Butzkueven Helmut, , Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis, 10.1371/journal.pone.0063480
  23. Rosenbaum Paul R., Observational Studies, ISBN:9781441931917, 10.1007/978-1-4757-3692-2
  24. Sekhon J, J Stat Software, 42 (2011)
  25. Etemadifar M., Janghorbani M., Shaygannejad V., Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis : Betaferon vs. Avonex and Rebif in multiple sclerosis, 10.1111/j.1600-0404.2006.00585.x
  26. Calabrese M, Bernardi V, Atzori M, Mattisi I, Favaretto A, Rinaldi F, Perini P, Gallo P, Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing–remitting multiple sclerosis, 10.1177/1352458510394702
  27. Gobbi Claudio, Zecca Chiara, Linnebank Michael, Müller Stefanie, You Xiaojun, Meier Rosetta, Borter Emmanuela, Traber Martin, Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies, 10.1159/000346761
  28. Goodin D. S., Frohman E. M., Hurwitz B., O'Connor P. W., Oger J. J., Reder A. T., Stevens J. C., Neutralizing antibodies to interferon beta: Assessment of their clinical and radiographic impact: An evidence report: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, 10.1212/01.wnl.0000258545.73854.cf
  29. La Mantia L, Cochrane Database Syst Rev, 7, CD009333 (2014)
  30. Filippini Graziella, Del Giovane Cinzia, Vacchi Laura, D'Amico Roberto, Di Pietrantonj Carlo, Beecher Deirdre, Salanti Georgia, Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis, 10.1002/14651858.cd008933.pub2
  31. Ming Kewei, Rosenbaum Paul R., Substantial Gains in Bias Reduction from Matching with a Variable Number of Controls, 10.1111/j.0006-341x.2000.00118.x
  32. Khan Omar, Rieckmann Peter, Boyko Alexey, Selmaj Krzysztof, Zivadinov Robert, , Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis : Glatiramer Acetate in RRMS, 10.1002/ana.23938